Can Creatine Supplementation Improve Body Composition and Objective Physical Function in Rheumatoid Arthritis Patients? A Randomized Controlled Trial
Open Access
- 26 May 2016
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 68 (6) , 729-737
Abstract
Objective: Rheumatoid cachexia (muscle wasting) in rheumatoid arthritis (RA) patients contributes to substantial reductions in strength and impaired physical function. The objective of this randomized controlled trial was to investigate the effectiveness of oral creatine (Cr) supplementation in increasing lean mass and improving strength and physical function in RA patients.Methods: In a double‐blind design, 40 RA patients were randomized to either 12 weeks’ supplementation of Cr or placebo. Body composition (dual x‐ray absorptiometry and bioelectrical impedance spectroscopy [BIS]), strength, and objectively assessed physical function were measured at baseline, day 6, week 12, and week 24. Data analysis was performed by analysis of covariance.Results: Cr supplementation increased appendicular lean mass (ALM; a surrogate measure of muscle mass) by mean ± SE 0.52 ± 0.13 kg (P = 0.004 versus placebo), and total LM by 0.60 ± 0.37 kg (P = 0.158). The change in LM concurred with the gain in intracellular water (0.64 ± 0.22 liters; P = 0.035) measured by BIS. Despite increasing ALM, Cr supplementation, relative to placebo, failed to improve isometric knee extensor strength (P = 0.408), handgrip strength (P = 0.833), or objectively assessed physical function (P = 0.335–0.764).Conclusion: In patients with RA, Cr supplementation increased muscle mass, but not strength or objective physical function. No treatment‐related adverse effects were reported, suggesting that Cr supplementation may offer a safe and acceptable adjunct treatment for attenuating muscle loss; this treatment may be beneficial for patients experiencing severe rheumatoid cachexia.Keywords
Funding Information
- Betsi Cadwaladr University Health Board Small Grants Committee (CF17-11)
This publication has 40 references indexed in Scilit:
- Creatine Supplementation in Fibromyalgia: A Randomized, Double‐Blind, Placebo‐Controlled TrialArthritis Care & Research, 2013
- Are the benefits of a high‐intensity progressive resistance training program sustained in rheumatoid arthritis patients? A 3‐year followup studyArthritis Care & Research, 2011
- In sickness and in health: the widespread application of creatine supplementationAmino Acids, 2011
- ISSN exercise & sport nutrition review: research & recommendationsJournal of the International Society of Sports Nutrition, 2010
- Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled StudyPLOS ONE, 2009
- Abnormal body composition phenotypes in older rheumatoid arthritis patients: Association with disease characteristics and pharmacotherapiesArthritis Care & Research, 2008
- Rheumatoid cachexia: a clinical perspectiveRheumatology, 2008
- A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10–20seconds for use in standard clinical care, without rulers, calculators, websites or computersBest Practice & Research Clinical Rheumatology, 2007
- Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1Muscle & Nerve, 2003
- SPECIFICITY OF CREATINE IN THE CONTROL OF MUSCLE PROTEIN SYNTHESISJournal of Cell Biology, 1974